Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $151.4300 (-1.31%) ($151.4300 - $153.8100) on Tue. Nov. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.95% (three month average) | RSI | 78 | Latest Price | $151.4300(-1.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 6.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(57%) IWC(54%) IWN(53%) | Factors Impacting LGND price | LGND will decline at least -1.475% in a week (0% probabilities). VIXM(-28%) VXX(-17%) UUP(-17%) UNG(-5%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.475% (StdDev 2.95%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $155.07(-2.35%) | 10 Day Moving Average | $151.96(-0.35%) | 20 Day Moving Average | $142.77(6.07%) | To recent high | -5.4% | To recent low | 47.8% | Market Cap | $2.434b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |